- About Overview
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Dean’s Office Overview
- Assistant Deans
- Associate Deans
- Education Unit
- Office of Academic Affairs
- Office of Finance and Administration
- Office of Planning and Communications
- Org chart
- Patient Care
Burchard’s research highlighted in Newsweek
By UCSF School of Pharmacy Editorial Staff / Tue Nov 3, 2015
Esteban G. Burchard, MD, MPH, has been featured in Newsweek for his work studying genetic variation in asthma among minority populations. The article, titled “The Racial Discrimination Embedded in Modern Medicine,” was published online on October 20. It addresses issues such as racial health disparities, precision medicine, and the importance of including minorities in clinical research.
Researchers in the Burchard Lab—known as the Asthma Collaboratory—study the interplay between genes and their social and physical environments to determine the root causes of asthma health disparities. “His research shows that ethnicity is the most important factor in determining whether a patient will respond to asthma therapy—even more important than the severity of the disease or the patient’s socioeconomic status,” states Newsweek.
Burchard is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.
About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.